MetLife (NYSE:MET) Releases Earnings Results, Beats Expectations By $0.13 EPS

MetLife (NYSE:MET) posted its quarterly earnings results on Wednesday. The financial services provider reported $2.43 earnings per share for the quarter, beating analysts’ consensus estimates of $2.30 by $0.13, Zacks reports. MetLife had a return on equity of 22.60% and a net margin of 4.66%.The firm had revenue of $13.52 billion for the quarter, compared to the consensus estimate of $19.67 billion. During the same period in the previous year, the business earned $2.02 earnings per share. The company’s revenue for the quarter was up 10.5% compared to the same quarter last year.

MetLife Price Performance

Shares of NYSE:MET traded up $3.79 during midday trading on Thursday, hitting $100.06. 3,811,667 shares of the stock were exchanged, compared to its average volume of 3,817,942. MetLife has a twelve month low of $67.33 and a twelve month high of $100.93. The company has a current ratio of 0.20, a quick ratio of 0.20 and a debt-to-equity ratio of 0.53. The company has a 50 day moving average price of $89.44 and a 200-day moving average price of $80.54. The stock has a market cap of $64.38 billion, a P/E ratio of 19.39, a PEG ratio of 0.74 and a beta of 0.78.

MetLife Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 8th. Stockholders of record on Tuesday, August 4th will be given a $0.5925 dividend. The ex-dividend date is Tuesday, August 4th. This represents a $2.37 dividend on an annualized basis and a dividend yield of 2.4%. MetLife’s dividend payout ratio (DPR) is currently 45.93%.

Hedge Funds Weigh In On MetLife

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Invesco Ltd. raised its position in shares of MetLife by 2.6% during the 4th quarter. Invesco Ltd. now owns 7,012,198 shares of the financial services provider’s stock worth $553,543,000 after purchasing an additional 176,811 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in MetLife by 2.5% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,201,175 shares of the financial services provider’s stock valued at $410,581,000 after buying an additional 126,098 shares in the last quarter. AQR Capital Management LLC grew its holdings in MetLife by 105.3% during the 3rd quarter. AQR Capital Management LLC now owns 3,305,620 shares of the financial services provider’s stock valued at $271,424,000 after buying an additional 1,695,563 shares during the last quarter. Stifel Financial Corp increased its position in MetLife by 1.2% during the fourth quarter. Stifel Financial Corp now owns 2,660,727 shares of the financial services provider’s stock worth $210,038,000 after buying an additional 32,554 shares in the last quarter. Finally, Deutsche Bank AG increased its position in MetLife by 47.9% during the fourth quarter. Deutsche Bank AG now owns 2,569,444 shares of the financial services provider’s stock worth $202,832,000 after buying an additional 831,986 shares in the last quarter. Institutional investors and hedge funds own 94.99% of the company’s stock.

MetLife declared that its board has initiated a stock repurchase program on Wednesday, August 5th that permits the company to buyback $3.00 billion in shares. This buyback authorization permits the financial services provider to reacquire up to 4.8% of its shares through open market purchases. Shares buyback programs are often a sign that the company’s leadership believes its stock is undervalued.

Analysts Set New Price Targets

A number of equities research analysts have commented on MET shares. Keefe, Bruyette & Woods raised their target price on MetLife from $98.00 to $105.00 and gave the company an “outperform” rating in a report on Monday, July 13th. Atlantic Securities set a $103.00 price target on shares of MetLife in a research note on Wednesday, July 15th. UBS Group increased their price target on shares of MetLife from $102.00 to $105.00 and gave the company a “buy” rating in a report on Wednesday, July 8th. Barclays boosted their price objective on shares of MetLife from $94.00 to $97.00 and gave the stock an “overweight” rating in a report on Thursday. Finally, Morgan Stanley upped their target price on shares of MetLife from $93.00 to $103.00 and gave the stock an “overweight” rating in a research report on Monday, July 6th. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, MetLife presently has a consensus rating of “Moderate Buy” and an average price target of $100.71.

Trending Headlines about MetLife

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: MetLife reported second-quarter adjusted earnings of $2.43 per share, exceeding the $2.30 analyst consensus and rising from $2.02 a year earlier. Higher investment income, favorable underwriting and business-volume growth supported the earnings beat. MetLife Tops Q2 Earnings Estimates on Strong Investment Income
• Positive Sentiment: Revenue increased 10.5% year over year to approximately $19.1 billion, while management commentary and analyst coverage pointed to resilient organic growth. MetLife’s return on equity was also strong at 22.6%. MetLife Q2 Earnings Beat Reaffirms the Buy Case
• Positive Sentiment: The board authorized a new $3 billion share-repurchase program, incremental to roughly $400 million remaining under the prior authorization. The program could cover up to about 4.8% of outstanding shares, signaling confidence in future capital generation and potentially supporting per-share results. MetLife Announces New $3 Billion Share Repurchase Authorization
• Neutral Sentiment: MetLife maintained its 2026 outlook for MetLife Investment Management operating earnings of $240 million to $280 million. MetLife Pet Insurance also received a 2026 industry award, offering positive brand recognition but limited near-term earnings impact. MetLife Outlines New Buyback Authorization
• Negative Sentiment: Quarterly revenue of approximately $19.1 billion fell short of the $19.67 billion consensus estimate, and higher expenses remain a consideration despite the overall earnings beat. MetLife Quarterly Earnings Results

About MetLife

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.